US FDA approves 24 drugs in May in busiest month of 2026
· amanda lanier
AI Briefing
- US FDA approved 24 drugs in May 2026, the busiest month of the year so far.
- This surpasses April's 14 approvals, bringing the year-to-date total to 84.
- The pace of approvals is on track to approach or exceed several recent years.
Source Summary
The U.S. FDA approved 24 drugs in May 2026, the busiest month of the year so far. Up from April’s 14, it brings the year-to-date total to 84 approvals. Through May, the agency has cleared 20 new molecular entities, a pace that, if sustained, would put 2026 on track to approach or exceed several recent years.
Advertisement